OSTX
OS Therapies Incorporated Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$1.840
Максимум
$1.840
Минимум
$1.840
Объем
0.08M
Фундаментальные показатели компании
Статистические данные торговли
Связанные новости
OS Therapies Partners with EVERSANA for the U.S. Commercialization of OST-HER2 in Recurrent, Fully Resected, Pediatric Lung Metastatic Osteosarcoma
OS Therapies Inc. (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology...
D. Boral Capital Maintains Buy on OS Therapies, Maintains $20 Price Target
D. Boral Capital analyst Jason Kolbert maintains OS Therapies with a Buy and maintains $20 price target.
OS Therapies Submits Request for Regenerative Medicine Advanced Therapy (RMAT) Designation to U.S. FDA for OST-HER2 in the Prevention of Metastases in Recurrent, Fully-Resected, Lung Metastatic Pediatric Osteosarcoma
If awarded, OST-HER2 would become the first listeria investigational medicinal product to be awarded the RMAT designation RMAT designation reduces BLA application review time and permits augmented interactions with
Связанные акции
BPTH
Bio-Path Holdings Inc.
TCBPW
TC BioPharm (Holdings) plc Warrants
MTD
Mettler Toledo
BIIB
Biogen Inc.
RLX
RLX Technology Inc. American Depositary Shares each representing the right to receive one (1) ordinary share
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.